English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/191349
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Lignin and cellulose blends as pharmaceutical excipient for tablet manufacturing via direct compression

AuthorsDomínguez-Robles, Juan; Stewart, Sarah A.; Rendl, Andreas; González Granados, Zoilo ; Donnelly, Ryan F.; Larrañeta, Eneko
Microcrystalline cellulose
Pharmaceutical excipients
Direct compression
Issue Date28-Aug-2019
PublisherMultidisciplinary Digital Publishing Institute
CitationBiomolecules 9(9): 423 (2019)
AbstractExtensive efforts are being made to find alternative uses for lignin (LIG). In the present work the use of this biopolymer as excipient to prepare tablets was studied. For this purpose, LIG was combined with microcrystalline cellulose (MCC) and used as excipients to prepare directly compressed tablets containing a model drug, tetracycline (TC). The excipients contained different concentrations of LIG: 100%, 75%, 50%, 25% and 0% (w/w). Two different compression forces were used (two and five tonnes). When formulations were prepared using LIG as the only excipient, tablets were formed, but they showed lower densities and crushing strength than the ones obtained with only MCC or LIG/MCC blends. Moreover, tablets prepared using five tonnes of compression force showed TC releases ranging from 40% to 70% of the drug loading. On the other hand, the tablets prepared using two tonnes of compression force showed a faster and more efficient TC release, between 60% and 90%. The presence of LIG in the tablets modified significantly the release profile and the maximum amount of TC released. Finally, a DPPH (2,2-diphenyl-1-picrylhydrozyl) assay was performed to confirm that the presence of LIG provided antioxidant properties to the formulations. Accordingly, LIG has potential as a pharmaceutical excipient
Description© The Author(s).
Publisher version (URL)https://doi.org/10.3390/biom9090423
Appears in Collections:(ICV) Artículos
Files in This Item:
File Description SizeFormat 
Lignin_Dominguez_Art2019.pdf3,76 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.